{
    "2019-03-05": [
        [
            {
                "time": "2019-01-01",
                "original_text": "前诺华中国区总裁徐海瑛，上任哈药总经理",
                "features": {
                    "keywords": [
                        "诺华",
                        "中国区总裁",
                        "哈药",
                        "总经理"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "重新审视中国医药市场 2019年国内外药企高层人事调整频繁",
                "features": {
                    "keywords": [
                        "医药市场",
                        "人事调整",
                        "2019年"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "上市至今暴涨10倍！医药并购之王！可股价狂跌56%，又是啥情况？",
                "features": {
                    "keywords": [
                        "暴涨",
                        "医药并购",
                        "股价狂跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "科创板、A股其他板块与港股市场IPO制度及定价估值体系对比分析——会议纪要",
                "features": {
                    "keywords": [
                        "科创板",
                        "IPO制度",
                        "定价估值"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "【晨会聚焦】银行股大行情的历史梳理：美好时光还会再现？",
                "features": {
                    "keywords": [
                        "银行股",
                        "历史梳理",
                        "大行情"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-04",
                "original_text": "【医药】江琦、赵磊：科创板专题报告：丰富医药创新企业上市路径，创新引领未来-20190304",
                "features": {
                    "keywords": [
                        "科创板",
                        "医药创新",
                        "上市路径",
                        "创新引领未来"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "医药生物行业周报:受益MSCI扩容,板块估值修复有望延续",
                "features": {
                    "keywords": [
                        "医药生物",
                        "MSCI扩容",
                        "估值修复"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}